Table 4.
Randomised participants | Preference participants | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Surgical | Medical | Surgical | Medical | ||||||||
Randomised (n=178) | Per protocol (n=111) | Randomised (n=179) | Per protocol (n=169) | Preference (n=261) | Per protocol (n=218) | Preference (n=192) | Per protocol (n=189) | ||||
Primary outcome (REFLUX QoL) | |||||||||||
Baseline | 63.6 (24.1) | 61.9 (24.5) | 66.8 (24.5) | 68.2 (24.2) | 55.8 (23.2) | 55.9 (23.2) | 77.5 (19.7) | 78.0 (19.1) | |||
3 months | 83.9 (19.4) | 85.9 (19.0) | 70.6 (24.6) | 70.8 (24.4) | 80.4 (21.6) | 82.5 (20.3) | 80.2 (18.2) | 80.6 (17.7) | |||
12 months | 84.6 (17.9) | 88.3 (15.6) | 73.4 (23.3) | 73.1 (23.7) | 83.3 (20.7) | 86.0 (17.9) | 79.2 (19.2) | 79.4 (19.0) | |||
Secondary outcome (EQ-5D index) | |||||||||||
Baseline | 0.71 (0.26) | 0.72 (0.24) | 0.72 (0.25) | 0.73 (0.25) | 0.68 (0.26) | 0.68 (0.26) | 0.75 (0.22) | 0.75 (0.22) | |||
3 months | 0.79 (0.23) | 0.81 (0.24) | 0.69 (0.30) | 0.70 (0.30) | 0.81 (0.25) | 0.82 (0.24) | 0.76 (0.23) | 0.77 (0.23) | |||
12 months | 0.75 (0.25) | 0.78 (0.23) | 0.71 (0.27) | 0.71 (0.27) | 0.79 (0.26) | 0.80 (0.25) | 0.74 (0.24) | 0.74 (0.24) |